Document Detail


Immunosuppressive therapy in inflammatory myocarditis: long-term follow-up.
MedLine Citation:
PMID:  1737666     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sixteen patients (12 male and 4 female, age 2-46 years) with endomyocardial biopsy-proven myocarditis were prospectively evaluated with immunosuppressive therapy including azathioprine and prednisolone in addition to other standard measures. Patients were either in NYHA class IV (n = 12) or class III (n = 4). Twelve patients showed improvement and the remaining 4 continued to deteriorate: 2 died at 1 and 2 months after therapy and the other 2 were lost to follow-up after 4-6 weeks of therapy. Three of the 12 patients who showed significant improvement, after sudden omission of therapy (at 8 weeks, 6 and 8 months) worsened and died. One patient who showed significant improvement died suddenly after 9 months of therapy while playing football. The remaining patients have shown significant clinical and haemodynamic improvement with normalization of myocardial morphology. Serial haemodynamic studies revealed a significant fall in cardiothoracic ratio (before: 62.3 +/- 4.7%; 3 months: 55.1 +/- 3.1%, P less than 0.0001; 6-12 months: 50.6 +/- 1.5%, P less than 0.0001), mean pulmonary artery pressure (before: 34.3 +/- 13.05 mm; 3 months: 20.4 +/- 8.71 mm, P less than 0.01; 6-12 months: 20.0 +/- 2.75 mm, P less than 0.01) and mean pulmonary artery wedge pressure (before: 26.0 +/- 9.07 mm; 3 months 14.0 +/- 5.63 mm, P less than 0.001; 6-12 months: 13.2 +/- 4.57 mm, P less than 0.001). The left ventricular ejection fraction improved from 24.3 +/- 8.36% to 35.8 +/- 9.72% (P less than 0.001) at 3 months and 49.8 +/- 18.2% (P less than 0.0001) at 6-12 months of therapy. Two patients have been subsequently lost to follow-up whereas the remaining 6 patients are on follow-up for 1-4 years after therapy and are doing fine. Our uncontrolled observations suggest that immunosuppressive therapy may be useful in patients with inflammatory myocarditis.
Authors:
K K Talwar; K C Goswami; P Chopra; V Dev; S Shrivastava; A Malhotra
Related Documents :
2969636 - Electrocardiogram in primary pulmonary hypertension--with special reference to prognosis.
3355286 - Fontan repair for tricuspid atresia: experience with 50 consecutive patients.
15975336 - Seven-year clinical experience with the extracardiac pedicled pericardial fontan operat...
9527086 - Outcome in cyanotic neonates with ebstein's anomaly.
15155426 - Subjective functional assessments and the return to competitive sport after anterior cr...
22974606 - The significance of detrusor wall thickness as a prognostic factor in pediatric bladder...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of cardiology     Volume:  34     ISSN:  0167-5273     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  1992 Feb 
Date Detail:
Created Date:  1992-03-19     Completed Date:  1992-03-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  157-66     Citation Subset:  IM    
Affiliation:
Department of Cardiology and Pathology, All India Institute of Medical Sciences, New Delhi.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Azathioprine / administration & dosage,  therapeutic use*
Child
Child, Preschool
Endocardium / pathology
Female
Follow-Up Studies
Hemodynamics
Humans
Male
Middle Aged
Myocarditis / drug therapy*,  pathology,  physiopathology
Myocardium / pathology
Prednisolone / administration & dosage,  therapeutic use*
Prospective Studies
Chemical
Reg. No./Substance:
446-86-6/Azathioprine; 50-24-8/Prednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adverse effects of epinephrine in patients with advanced left ventricular dysfunction: analysis of v...
Next Document:  Propionyl-L-carnitine: a new compound in the metabolic approach to the treatment of effort angina.